Multiple Sclerosis Trial, Recruiting NCT06292312 Sponsor: Ankara Yildirim Beyazıt University Condition: Multiple Sclerosis
Back to Multiple Sclerosis

Multiple Sclerosis Trial, Recruiting

NCT06292312
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged between 18 and 65 years old
  • People who have been formally diagnosed with multiple sclerosis (MS) by a neurologist
  • People whose MS-related disability falls within a specific range on a standard neurologist-rated scale called the EDSS, scoring between 1 and 5.5 (confirm with trial site)
  • People who are not currently receiving physical therapy services
  • People who are willing to volunteer to take part

Who may not be able to join:

  • People who have a neurological condition other than MS
  • People who have had an MS attack (relapse) within the last three months
  • People who are currently using corticosteroid medications (a type of anti-inflammatory drug)
  • People who have had surgery on their spine at any point
  • People who have a disease affecting the central or peripheral nervous system
  • People who are pregnant
  • People who have or have had a cancer-related (oncological) disease
  • People who have serious physical or mental health conditions alongside their MS
  • People who are currently receiving invasive or hands-on manipulative treatments (confirm with trial site for examples of what this includes)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 16 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Hilal Aslan, MSc, Ankara Yildirim Beyazıt University

Phone: 05372565397

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Ankara Yildirim Beyazıt University
Registry
ClinicalTrials.gov
Start date
27 February 2024
Est. completion
15 April 2025

Where this trial is recruiting

Turkey (Türkiye)

Primary endpoints

Dynamic posturography; Heart rate variability; Number of participants

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov